Skip to content

Digital care program for older adults with depressive symptoms in primary care

Digital care program for older adults with depressive symptoms in primary care

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-6c7ghfd
Enrollment
Unknown
Registered
2021-10-21
Start date
2021-09-20
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

Participants will receive automated messages through the WhatsApp Business application according to the allocation group. Participants will also receive reminders to visit a health professional in cas
(2) behaviour and well-being
(3) organising activities
(4) specific question on depressive symptoms
(5) review
and (6) well-being after the programme (relapse prevention). Control group: The control group (n=225) will receive one audio message and one meme image with general information about subthreshold de

Sponsors

King's College London
Collaborator
Faculdade de Medicina da Universidade de São Paulo
Lead Sponsor

Eligibility

Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: Registered with one of the participating clinics or organisation; aged 60 or over; scores of PHQ-2 higher than 0 (first two questions of PHQ-9) and PHQ-9 between 5 and 9; able to receive live calls and WhatsApp messages (audio and images) on a mobile phone

Exclusion criteria

Exclusion criteria: Unable to communicate (non-Portuguese speaking, cognitively impaired or other problem hindering communication to engage in trial assessment and intervention such as vision or hearing problems, terminal illness or severe mental illness); individuals presenting suicidal risk during the two weeks prior to the screening assessment, as assessed by the 9th item of the PHQ-9 and Immediate Suicide Risk Protocol

Design outcomes

Primary

MeasureTime frame
Difference in the means of the 9-item Patient Health Questionnaire (PHQ-9) score assessed at three months after entering into the trial.

Secondary

MeasureTime frame
Difference in the means of the PHQ-9 score will also be assessed at five months to assess the maintenance of any earlier clinical gains. Moreover, general quality of life using the 5-item EuroQol (EQ-5D-5L), ICECAP-O, generalized Anxiety Disorder 7-item scale (GAD-7) and three-item UCLA Loneliness scale (3-item UCLA) will be measured at three and five months.

Countries

Brazil

Contacts

Public ContactMarcia Scazufca
scazufca@usp.br+551126617268

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 6, 2026